Clinical Virology Unit 1

1. BNT162b2 vaccine induces potent SARS-CoV-2 neutralising immunoglobulins in lung mucosa
2. Intramuscular mRNA BNT162b2 vaccine against SARS-CoV-2 induces neutralizing salivary IgA
3. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
1